UK authorizes Merck's coronavirus pill, the first shown to be effective at treating COVID-19

The pill was licensed for adults 18 and older who have tested positive for COVID-19 and have at least one risk factor for developing severe disease. The drug, known as molnupiravir, is intended to be taken twice a day for five days by people at home with mild to moderate COVID-19.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2ZWpUxG
via IFTTT